Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results

Paolo Anderlini; Rima M. Saliba; Celina Ledesma; Christina Chancoco; Amin M. Alousi; Elizabeth J. Shpall; Uday R. Popat; Chitra M. Hosing; Issa F. Khouri; Yago Nieto; Stefan Ciurea; Anas Younes; Michelle A. Fanale; Sandra Acholonu; Rosamar Valverde; Richard E. Champlin

doi:10.3109/10428194.2011.615427

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results

Paolo Anderlini, Rima M. Saliba, Celina Ledesma, Christina Chancoco, Amin M. Alousi, Elizabeth J. Shpall, Uday R. Popat, Chitra M. Hosing, Issa F. Khouri, Yago Nieto, Stefan Ciurea, Anas Younes, Michelle A. Fanale, Sandra Acholonu, Rosamar Valverde, Richard E. Champlin

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	499-502
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	53
Issue number	3
DOIs	https://doi.org/10.3109/10428194.2011.615427
State	Published - Mar 2012

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2011.615427

Cite this

Anderlini, P., Saliba, R. M., Ledesma, C., Chancoco, C., Alousi, A. M., Shpall, E. J., Popat, U. R., Hosing, C. M., Khouri, I. F., Nieto, Y., Ciurea, S., Younes, A., Fanale, M. A., Acholonu, S., Valverde, R., & Champlin, R. E. (2012). Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results. Leukemia and Lymphoma, 53(3), 499-502. https://doi.org/10.3109/10428194.2011.615427

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results. / Anderlini, Paolo; Saliba, Rima M.; Ledesma, Celina et al.
In: Leukemia and Lymphoma, Vol. 53, No. 3, 03.2012, p. 499-502.

Research output: Contribution to journal › Letter › peer-review

Anderlini, P, Saliba, RM, Ledesma, C, Chancoco, C, Alousi, AM , Shpall, EJ , Popat, UR , Hosing, CM , Khouri, IF , Nieto, Y, Ciurea, S, Younes, A, Fanale, MA, Acholonu, S, Valverde, R & Champlin, RE 2012, 'Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results', Leukemia and Lymphoma, vol. 53, no. 3, pp. 499-502. https://doi.org/10.3109/10428194.2011.615427

@article{3854dfc252fa428fb876bb74a35a5b4b,

title = "Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results",

author = "Paolo Anderlini and Saliba, {Rima M.} and Celina Ledesma and Christina Chancoco and Alousi, {Amin M.} and Shpall, {Elizabeth J.} and Popat, {Uday R.} and Hosing, {Chitra M.} and Khouri, {Issa F.} and Yago Nieto and Stefan Ciurea and Anas Younes and Fanale, {Michelle A.} and Sandra Acholonu and Rosamar Valverde and Champlin, {Richard E.}",

year = "2012",

month = mar,

doi = "10.3109/10428194.2011.615427",

language = "English (US)",

volume = "53",

pages = "499--502",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma

T2 - Preliminary results

AU - Anderlini, Paolo

AU - Saliba, Rima M.

AU - Ledesma, Celina

AU - Chancoco, Christina

AU - Alousi, Amin M.

AU - Shpall, Elizabeth J.

AU - Popat, Uday R.

AU - Hosing, Chitra M.

AU - Khouri, Issa F.

AU - Nieto, Yago

AU - Ciurea, Stefan

AU - Younes, Anas

AU - Fanale, Michelle A.

AU - Acholonu, Sandra

AU - Valverde, Rosamar

AU - Champlin, Richard E.

PY - 2012/3

Y1 - 2012/3

UR - http://www.scopus.com/inward/record.url?scp=84857565259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857565259&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.615427

DO - 10.3109/10428194.2011.615427

M3 - Letter

C2 - 21859247

AN - SCOPUS:84857565259

SN - 1042-8194

VL - 53

SP - 499

EP - 502

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this